Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
26 hedge funds and large institutions have $37.6M invested in Roivant Sciences Ltd. Warrant in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
13% more funds holding
Funds holding: 23 → 26 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $42.1M → $37.6M (-$4.52M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
+$2.21M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$544K |
| 3 |
SOA
Sea Otter Advisors
Miami,
Florida
|
+$455K |
| 4 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$293K |
| 5 |
TSC
Two Seas Capital
Rye,
New York
|
+$291K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$1.25M |
| 2 |
Walleye Capital
New York
|
-$590K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$504K |
| 4 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$87.3K |
| 5 |
Jane Street
New York
|
-$3.03K |
ROIVW Hedge Fund Activity: Q2 2023 in Review
26 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q2 2023, worth a combined $37.6M — down 11% from $42.1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ROIVW positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Fort Baker Capital Management, opening a new position worth an estimated $2.21M. The largest seller was Aristeia Capital, cutting an estimated $1.25M.
- 26 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q2 2023, up from 23 in Q1 2023.
- Funds reported $37.6M of Roivant Sciences Ltd. Warrant stock for Q2 2023, down 11% quarter-over-quarter.
- 4 funds opened new Roivant Sciences Ltd. Warrant positions in Q2 2023 and 1 closed out, a net change of +3 holders.
- The largest Roivant Sciences Ltd. Warrant buyer in Q2 2023 was Fort Baker Capital Management, an estimated $2.21M added.
- The largest Roivant Sciences Ltd. Warrant seller in Q2 2023 was Aristeia Capital, an estimated $1.25M sold.
Based on aggregated 13F filings for Q2 2023.